Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up

L O Ramig, S Sapir, S Countryman, A A Pawlas, C O'Brien, M Hoehn, L L Thompson, L O Ramig, S Sapir, S Countryman, A A Pawlas, C O'Brien, M Hoehn, L L Thompson

Abstract

Objectives: To assess long term (24 months) effects of the Lee Silverman voice treatment (LSVT), a method designed to improve vocal function in patients with Parkinson's disease.

Methods: Thirty three patients with idiopathic Parkinson's disease were stratified and randomly assigned to two treatment groups. One group received the LSVT, which emphasises high phonatory-respiratory effort. The other group received respiratory therapy (RET), which emphasises high respiratory effort alone. Patients in both treatment groups sustained vowel phonation, read a passage, and produced a monologue under identical conditions before, immediately after, and 24 months after speech treatment. Change in vocal function was measured by means of acoustic analyses of voice loudness (measured as sound pressure level, or SPL) and inflection in voice fundamental frequency (measured in terms of semitone standard deviation, or STSD).

Results: The LSVT was significantly more effective than the RET in improving (increasing) SPL and STSD immediately post-treatment and maintaining those improvements at 2 year follow up.

Conclusions: The findings provide evidence for the efficacy of the LSVT as well as the long term maintenance of these effects in the treatment of voice and speech disorders in patients with idiopathic Parkinson's disease.

References

    1. J Voice. 2001 Mar;15(1):105-14
    1. Arch Intern Med. 1959 Sep;104:439-68
    1. J Speech Hear Res. 1969 Jun;12(2):246-69
    1. J Speech Hear Res. 1969 Sep;12(3):462-96
    1. J Speech Hear Disord. 1978 Feb;43(1):47-57
    1. Brain Lang. 1982 Mar;15(2):234-48
    1. J Neurol Neurosurg Psychiatry. 1983 Feb;46(2):140-4
    1. Laryngoscope. 1984 Mar;94(3):348-53
    1. Can J Neurol Sci. 1984 Feb;11(1 Suppl):129-35
    1. Psychiatry Res. 1984 Mar;11(3):223-35
    1. Br J Disord Commun. 1984 Dec;19(3):213-24
    1. Br J Disord Commun. 1985 Dec;20(3):289-96
    1. J Acoust Soc Am. 1989 Jan;85(1):295-312
    1. J Am Geriatr Soc. 1989 Apr;37(4):359-63
    1. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):201-6
    1. Otolaryngol Head Neck Surg. 1990 Mar;102(3):212-8
    1. Br J Disord Commun. 1990 Aug;25(2):183-94
    1. J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):454-60
    1. J Speech Hear Res. 1993 Apr;36(2):294-310
    1. Neurology. 1993 Dec;43(12 Suppl 6):S45-6
    1. J Neurol Neurosurg Psychiatry. 1994 Dec;57(12):1532-4
    1. J Acoust Soc Am. 1995 Mar;97(3):1885-92
    1. J Speech Hear Res. 1995 Aug;38(4):751-64
    1. J Voice. 1995 Dec;9(4):453-9
    1. J Speech Hear Res. 1995 Dec;38(6):1189-98
    1. J Speech Hear Res. 1995 Dec;38(6):1232-51
    1. J Voice. 1996 Dec;10(4):354-61
    1. Neurology. 1996 Dec;47(6):1496-504
    1. Mov Disord. 1997 May;12(3):306-14
    1. Ann Otol Rhinol Laryngol. 1997 Jul;106(7 Pt 1):544-51
    1. Acta Neurol Scand. 1997 Oct;96(4):199-205
    1. J Speech Lang Hear Res. 1998 Oct;41(5):1003-18
    1. Neurology. 1998 Dec;51(6):1592-8
    1. Disabil Rehabil. 1999 Feb;21(2):68-73
    1. Semin Clin Neuropsychiatry. 1999 Jan;4(1):34-40
    1. Neurology. 1967 May;17(5):427-42

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir